Skip to main content

and
  1. No Access

    Article

    Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments

    Metabolic programming controls immune cell lineages and functions, but little is known about γδ T cell metabolism. Here, we found that γδ T cell subsets making either interferon-γ (IFN-γ) or interleukin (IL)-1...

    Noella Lopes, Claire McIntyre, Stefania Martin, Mathilde Raverdeau in Nature Immunology (2021)

  2. No Access

    Article

    Metabolic reprogramming of natural killer cells in obesity limits antitumor responses

    Up to 49% of certain types of cancer are attributed to obesity, and potential mechanisms include overproduction of hormones, adipokines, and insulin. Cytotoxic immune cells, including natural killer (NK) cells...

    Xavier Michelet, Lydia Dyck, Andrew Hogan, Roisin M. Loftus in Nature Immunology (2018)

  3. Article

    Open Access

    Loss of the molecular clock in myeloid cells exacerbates T cell-mediated CNS autoimmune disease

    The transcription factor BMAL1 is a core component of the molecular clock, regulating biological pathways that drive 24 h (circadian) rhythms in behaviour and physiology. The molecular clock has a profound inf...

    Caroline E. Sutton, Conor M. Finlay, Mathilde Raverdeau in Nature Communications (2017)

  4. No Access

    Article

    Anti-PD-1 inhibits Foxp3+ Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse model

    The co-inhibitory molecule PD-1 suppresses T cell responses and has been targeted in the treatment of cancer. Here, we examined the role of PD-1 in regulating the balance between regulatory and effector T cell...

    Lydia Dyck, Mieszko M. Wilk, Mathilde Raverdeau in Cancer Immunology, Immunotherapy (2016)

  5. Article

    Open Access

    Development of a quantitative fluorescence-based ligand-binding assay

    A major goal of biology is to develop a quantitative ligand-binding assay that does not involve the use of radioactivity. Existing fluorescence-based assays have a serious drawback due to fluorescence quenchin...

    Conor J. Breen, Mathilde Raverdeau, H. Paul Voorheis in Scientific Reports (2016)